TW251288B - - Google Patents

Info

Publication number
TW251288B
TW251288B TW81104508A TW81104508A TW251288B TW 251288 B TW251288 B TW 251288B TW 81104508 A TW81104508 A TW 81104508A TW 81104508 A TW81104508 A TW 81104508A TW 251288 B TW251288 B TW 251288B
Authority
TW
Taiwan
Application number
TW81104508A
Other languages
Chinese (zh)
Original Assignee
Takeda Dharm Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Dharm Industry Co Ltd filed Critical Takeda Dharm Industry Co Ltd
Application granted granted Critical
Publication of TW251288B publication Critical patent/TW251288B/zh

Links

TW81104508A 1991-06-27 1992-06-10 TW251288B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15719491 1991-06-27
JP18888291 1991-07-29
JP19205491 1991-07-31
JP28821791 1991-08-12
JP23976491 1991-09-19

Publications (1)

Publication Number Publication Date
TW251288B true TW251288B (en) 1995-07-11

Family

ID=27528143

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81104508A TW251288B (en) 1991-06-27 1992-06-10

Country Status (2)

Country Link
CN (1) CN1040755C (en)
TW (1) TW251288B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI447114B (en) * 2011-09-30 2014-08-01 Sunshine Lake Pharma Co Ltd Novel crystalline forms of azilsartan and preparation thereof

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101151260B (en) * 2005-03-30 2011-06-29 武田药品工业株式会社 Benzimidazole derivative and use as angiotensin ii antagonist
MA33071B1 (en) * 2009-01-30 2012-02-01 Takeda Pharmaceutical Composite of intensive nucleus and its use
MX2012005776A (en) * 2009-11-30 2012-06-13 Jiangsu Hansoh Pharmaceutical Group Co Ltd Azilsartan organic amine salts, preparation method and use thereof.
CZ306650B6 (en) * 2011-03-04 2017-04-19 Zentiva, K.S. A method of manufacturing of 2-ethoxy-1-((2'-((hydroxyamino)iminomethyl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid and its esters, key intermediates of azilsartan synthesis
CN102827153B (en) * 2011-06-14 2016-10-05 江苏豪森药业集团有限公司 Crystal formation of Azilsartan and preparation method thereof
CN102731491B (en) * 2012-07-04 2015-03-18 北京科莱博医药开发有限责任公司 Preparation method of azilsartan intermediate
CN102731408A (en) * 2012-07-20 2012-10-17 江苏先声药物研究有限公司 Azilsartan intermediate and preparation method thereof
CN102766139B (en) * 2012-08-14 2014-09-17 江苏先声药物研究有限公司 Azilsartan polymorphic substance and preparation method thereof
CN103113364B (en) * 2012-08-27 2015-11-18 南京华威医药科技开发有限公司 The polymorphous preparation method of Azilsartan
CN103664920B (en) * 2012-09-24 2016-03-09 上海医药工业研究院 Azilsartan intermediate and the preparation method with Azilsartan thereof
CN103880830B (en) * 2013-03-22 2017-01-18 江西同和药业股份有限公司 Synthesis method of azilsartan
CN104072490A (en) * 2013-03-28 2014-10-01 江苏柯菲平医药有限公司 Preparation method of azilsartan key intermediate
CN104119326B (en) * 2013-04-25 2017-04-26 正大天晴药业集团股份有限公司 Method for preparing azilsartan
CN103242305B (en) * 2013-05-11 2018-02-27 迪沙药业集团有限公司 A kind of preparation method of Azilsartan
CN103372017A (en) * 2013-07-04 2013-10-30 丁圣雨 Application of Chukrasone A in preparation of medicines for treating atherosclerosis
CN103408500B (en) * 2013-07-25 2016-03-16 上海博志研新药物技术有限公司 The preparation method of a kind of Angiotensin Ⅱ receptor antagonist and key intermediate thereof
CN104418807A (en) * 2013-09-09 2015-03-18 天津药物研究院 Preparation method of 2-ethoxyl-1-[[2'-(hydroxyl amidino)-biphenylyl]-4-yl]methyl-1H-benzimidazole-7-carboxylic acid and ester derivatives thereof
CN106032378B (en) * 2015-03-20 2019-10-25 武汉启瑞药业有限公司 New A RB compound and application thereof
CN106478515B (en) * 2016-10-13 2018-11-23 艾美科健(中国)生物医药有限公司 A kind of preparation method of Azilsartan intermediate
CN110194749B (en) * 2019-07-08 2022-04-26 福州大学 Method for synthesizing 3-trifluoro (difluoro) methyl-1, 2, 4-triazole-5-ketone compound
CN112745302A (en) * 2019-10-31 2021-05-04 上海中医药大学附属龙华医院 Benzimidazole compound and medical application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
CA2020073A1 (en) * 1989-07-03 1991-01-04 Eric E. Allen Substituted quinazolinones as angiotensin ii antagonists

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI447114B (en) * 2011-09-30 2014-08-01 Sunshine Lake Pharma Co Ltd Novel crystalline forms of azilsartan and preparation thereof
US9174973B2 (en) 2011-09-30 2015-11-03 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan and preparation and uses thereof

Also Published As

Publication number Publication date
CN1067890A (en) 1993-01-13
CN1040755C (en) 1998-11-18

Similar Documents

Publication Publication Date Title
DK0616505T3 (en)
DK0578681T3 (en)
EP0507403A3 (en)
DE4291263T1 (en)
EP0520216A3 (en)
DE4193446T1 (en)
TW251288B (en)
FR2672423B1 (en)
EP0543296A3 (en)
FR2672239B1 (en)
FR2674074B1 (en)
FR2671520B1 (en)
ECSM91555U (en)
EP0560985A4 (en)
EP0548569A3 (en)
AU8969491A (en)
EP0519843A3 (en)
EP0512924A3 (en)
EP0498369A3 (en)
EP0500121A3 (en)
EP0520416A3 (en)
EP0543485A3 (en)
AU7138491A (en)
EP0538136A3 (en)
AU8570891A (en)